AAAAAA

   
Results: 1-10 |
Results: 10
BOSENTAN IN ESSENTIAL-HYPERTENSION
Authors: HAYNES WG FERRO CJ WEBB DJ
Citation: Wg. Haynes et al., BOSENTAN IN ESSENTIAL-HYPERTENSION, The New England journal of medicine, 339(5), 1998, pp. 346-346
INHIBITION OF NEUTRAL ENDOPEPTIDASE CAUSES VASOCONSTRICTION OF HUMAN RESISTANCE VESSELS IN-VIVO
Authors: FERRO CJ SPRATT JC HAYNES WG WEBB DJ
Citation: Cj. Ferro et al., INHIBITION OF NEUTRAL ENDOPEPTIDASE CAUSES VASOCONSTRICTION OF HUMAN RESISTANCE VESSELS IN-VIVO, Circulation, 97(23), 1998, pp. 2323-2330
SYSTEMIC INFUSION OF AN ENDOTHELIN RECEPTOR ANTAGONIST INCREASES PLASMA ET-3 IN HUMANS
Authors: DAVENPORT AP PLUMPTON C FERRO CJ WEBB DJ HORTON J
Citation: Ap. Davenport et al., SYSTEMIC INFUSION OF AN ENDOTHELIN RECEPTOR ANTAGONIST INCREASES PLASMA ET-3 IN HUMANS, British Journal of Pharmacology, 123, 1998, pp. 290-290
THE PEPTIDE ENDOTHELIN RECEPTOR ANTAGONIST, TAK-044, PRODUCES SUSTAINED INHIBITION OF ENDOTHELIN-1 MEDIATED ARTERIOLAR VASOCONSTRICTION
Authors: FERRO CJ HAYNES WG JOHNSTON NR LOMAX CC NEWBY DE WEBB DJ
Citation: Cj. Ferro et al., THE PEPTIDE ENDOTHELIN RECEPTOR ANTAGONIST, TAK-044, PRODUCES SUSTAINED INHIBITION OF ENDOTHELIN-1 MEDIATED ARTERIOLAR VASOCONSTRICTION, British journal of clinical pharmacology, 44(4), 1997, pp. 377-383
ENDOTHELIAL DYSFUNCTION AND HYPERTENSION
Authors: FERRO CJ WEBB DJ
Citation: Cj. Ferro et Dj. Webb, ENDOTHELIAL DYSFUNCTION AND HYPERTENSION, Drugs, 53, 1997, pp. 30-41
THE CLINICAL POTENTIAL OF ENDOTHELIN RECEPTOR ANTAGONISTS IN CARDIOVASCULAR MEDICINE
Authors: FERRO CJ WEBB DJ
Citation: Cj. Ferro et Dj. Webb, THE CLINICAL POTENTIAL OF ENDOTHELIN RECEPTOR ANTAGONISTS IN CARDIOVASCULAR MEDICINE, Drugs, 51(1), 1996, pp. 12-27
SELECTIVE OR NONSELECTIVE ENDOTHELIN RECEPTOR BLOCKADE IN CHRONIC HEART-FAILURE
Authors: LOVE MP FERRO CJ HAYNES WG WEBB DJ MCMURRAY JJ
Citation: Mp. Love et al., SELECTIVE OR NONSELECTIVE ENDOTHELIN RECEPTOR BLOCKADE IN CHRONIC HEART-FAILURE, Circulation, 94(8), 1996, pp. 425-425
SYSTEMIC ENDOTHELIN RECEPTOR BLOCKADE DECREASES PERIPHERAL VASCULAR-RESISTANCE AND BLOOD-PRESSURE IN HUMANS
Authors: HAYNES WG FERRO CJ OKANE KPJ SOMERVILLE D LOMAX CC WEBB DJ
Citation: Wg. Haynes et al., SYSTEMIC ENDOTHELIN RECEPTOR BLOCKADE DECREASES PERIPHERAL VASCULAR-RESISTANCE AND BLOOD-PRESSURE IN HUMANS, Circulation, 93(10), 1996, pp. 1860-1870
THE INCREASE IN HUMAN PLASMA-IMMUNOREACTIVE ENDOTHELIN BUT NOT BIG ENDOTHELIN-1 OR ITS C-TERMINAL FRAGMENT INDUCED BY SYSTEMIC ADMINISTRATION OF THE ENDOTHELIN ANTAGONIST TAK-044
Authors: PLUMPTON C FERRO CJ HAYNES WG WEBB DJ DAVENPORT AP
Citation: C. Plumpton et al., THE INCREASE IN HUMAN PLASMA-IMMUNOREACTIVE ENDOTHELIN BUT NOT BIG ENDOTHELIN-1 OR ITS C-TERMINAL FRAGMENT INDUCED BY SYSTEMIC ADMINISTRATION OF THE ENDOTHELIN ANTAGONIST TAK-044, British Journal of Pharmacology, 119(2), 1996, pp. 311-314
THE ENDOTHELIN ANTAGONIST TAK-044 INCREASES HUMAN PLASMA-IMMUNOREACTIVE ENDOTHELIN BUT NOT BIG ENDOTHELIN-1 OR C-TERMINAL FRAGMENT OF BIG ENDOTHELIN-1
Authors: PLUMPTON C FERRO CJ HAYNES WG WEBB DJ DAVENPORT AP
Citation: C. Plumpton et al., THE ENDOTHELIN ANTAGONIST TAK-044 INCREASES HUMAN PLASMA-IMMUNOREACTIVE ENDOTHELIN BUT NOT BIG ENDOTHELIN-1 OR C-TERMINAL FRAGMENT OF BIG ENDOTHELIN-1, British Journal of Pharmacology, 117, 1996, pp. 32-32
Risultati: 1-10 |